skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Active Site Conformational Dynamics in Human Uridine Phosphorylase 1

Journal Article · · PLoS ONE
 [1];  [1]
  1. Nevada Cancer Inst., Las Vegas, NV (United States). Dept. of Drug Development

Uridine phosphorylase (UPP) is a central enzyme in the pyrimidine salvage pathway, catalyzing the reversible phosphorolysis of uridine to uracil and ribose-1-phosphate. Human UPP activity has been a focus of cancer research due to its role in activating fluoropyrimidine nucleoside chemotherapeutic agents such as 5-fluorouracil (5-FU) and capecitabine. Additionally, specific molecular inhibitors of this enzyme have been found to raise endogenous uridine concentrations, which can produce a cytoprotective effect on normal tissues exposed to these drugs. Here we report the structure of hUPP1 bound to 5-FU at 2.3 Å resolution. Analysis of this structure reveals new insights as to the conformational motions the enzyme undergoes in the course of substrate binding and catalysis. The dimeric enzyme is capable of a large hinge motion between its two domains, facilitating ligand exchange and explaining observed cooperativity between the two active sites in binding phosphate-bearing substrates. Further, a loop toward the back end of the uracil binding pocket is shown to flexibly adjust to the varying chemistry of different compounds through an ‘‘induced-fit’’ association mechanism that was not observed in earlier hUPP1 structures. The details surrounding these dynamic aspects of hUPP1 structure and function provide unexplored avenues to develop novel inhibitors of this protein with improved specificity and increased affinity. Given the recent emergence of new roles for uridine as a neuron protective compound in ischemia and degenerative diseases, such as Alzheimer’s and Parkinson’s, inhibitors of hUPP1 with greater efficacy, which are able to boost cellular uridine levels without adverse side-effects, may have a wide range of therapeutic applications.

Research Organization:
SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States). Stanford Synchrotron Radiation Lightsource (SSRL)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institutes of Health (NIH); National Center for Research Resources (NCRR)
Grant/Contract Number:
AC02-76SF00515; P20 RR-016464
OSTI ID:
1627423
Journal Information:
PLoS ONE, Vol. 5, Issue 9; ISSN 1932-6203
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
English

References (33)

The kinetic mechanism of human uridine phosphorylase 1: Towards the development of enzyme inhibitors for cancer chemotherapy journal May 2010
Pentose phosphates in nucleoside interconversion and catabolism journal March 2006
Structural basis for inhibition of Escherichia coli uridine phosphorylase by 5-substituted acyclouridines journal June 2005
Glycal Formation in Crystals of Uridine Phosphorylase , journal April 2010
Crystallization and preliminary X-ray diffraction analysis of Salmonella typhimurium uridine phosphorylase complexed with 5-fluorouracil journal May 2009
Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: Influence of sex and inhibitors journal January 2006
Coot model-building tools for molecular graphics journal November 2004
Implications of the structure of human uridine phosphorylase 1 on the development of novel inhibitors for improving the therapeutic window of fluoropyrimidine chemotherapy journal January 2009
Uridine Phosphorylase Association with Vimentin journal April 2001
Crystal Structures of Escherichia coli Uridine Phosphorylase in Two Native and Three Complexed Forms Reveal Basis of Substrate Specificity, Induced Conformational Changes and Influence of Potassium journal March 2004
Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Enhances Antiproliferative Activity of 5′-Deoxy-5-Fluorouridine in Cancer Cells through Induction of Uridine Phosphorylase journal July 2009
The Crystal Structure and Activity of a Putative Trypanosomal Nucleoside Phosphorylase Reveal It to be a Homodimeric Uridine Phosphorylase journal March 2010
Uridine phosophorylase: An important enzyme in pyrimidine metabolism and fluoropyrimidine activation journal January 2004
Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease journal November 2008
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids journal May 2007
Identification of a Liver-Specific Uridine Phosphorylase that Is Regulated by Multiple Lipid-Sensing Nuclear Receptors journal April 2004
Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils journal July 2008
Uridine Protects Cortical Neurons from Glucose Deprivation-Induced Death: Possible Role of Uridine Phosphorylase journal June 2008
Main-chain Bond Lengths and Bond Angles in Protein Structures journal June 1993
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions journal January 1995
The CCP4 suite programs for protein crystallography journal September 1994
Cloning and Expression of Human Uridine Phosphorylase journal November 1995
Uridine prevents the glucose deprivation-induced death of immunostimulated astrocytes via the action of uridine phosphorylase journal September 2006
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
5-Benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase journal May 1982
Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor journal March 2006
Atomic structure at 2.5 Å resolution of uridine phosphorylase from E. coli as refined in the monoclinic crystal lattice journal June 1995
Identification of a novel human uridine phosphorylase journal July 2003
In vitro assessment of salvage pathways for pyrimidine bases in rat liver and brain journal October 1998
Structure of Escherichia coli uridine phosphorylase at 2.0 Å journal December 2002
The X-ray structure of Salmonella typhimurium uridine nucleoside phosphorylase complexed with 2,2′-anhydrouridine, phosphate and potassium ions at 1.86 Å resolution journal December 2009
Preliminary investigation of the three-dimensional structure of Salmonella typhimurium uridine phosphorylase in the crystalline state
  • Dontsova, Maria V.; Gabdoulkhakov, Azat G.; Molchan, Olga K.
  • Acta Crystallographica Section F Structural Biology and Crystallization Communications, Vol. 61, Issue 4 https://doi.org/10.1107/s1744309105007463
journal March 2005
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids text January 2007

Cited By (2)

Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines journal August 2019
A six‑gene support vector machine classifier contributes to the diagnosis of pediatric septic shock journal January 2020